Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 14;40(17):2491-2497.
doi: 10.1016/j.vaccine.2021.07.006. Epub 2021 Jul 17.

Vaccinating Australia: How long will it take?

Affiliations

Vaccinating Australia: How long will it take?

Mark Hanly et al. Vaccine. .

Abstract

The Australian Government began to roll out the national COVID-19 vaccination program in late February 2021, with the initial aim to vaccinate the Australian adult population by the end of October 2021. The task of vaccinating some 20 million people presents considerable logistic challenges, but a rapid rollout is essential to allow for the reopening of borders and is especially urgent as new more transmissible variants arise. Here, we run a series of projections to estimate how long it will take to vaccinate the Australian population under different assumptions about the rate of vaccine administration, the schedule for vaccine eligibility and prevalence of vaccine hesitancy. Our analysis highlights the number of vaccine doses that can be administered per day as the key factor determining the duration of the vaccine rollout. A rate of 200,000 doses per day would achieve 90% population coverage by the end of 2021; 80,000 doses a day would see the rollout extended until mid-2023. Vaccine hesitancy has the potential to greatly slow down the rollout and becomes the main limiting factor when the supply of vaccine doses is high. Speed is of the essence when it comes vaccinating populations against COVID-19: a rapid rollout will minimise the risk of sporadic and costly lockdowns and the potential for small, local clusters getting out of control and sparking new epidemic waves. In order to achieve rapid population coverage, the Australian government must ramp up vaccine administration to at least 200,000 doses per day as quickly as possible, while also promoting vaccine willingness in the community through clear public health messaging, especially to known hesitant demographics.

Keywords: Australia; COVID-19; Vaccination.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [Raina MacIntyre has been on an advisory board for COVID-19 vaccine for Seqirus and consulted or done speaking engagements on COVID-19 vaccines for Janssen and Astra Zeneca].

Figures

Fig. 1
Fig. 1
Cumulative vaccine doses over time.
Fig. 2
Fig. 2
Daily COVID-19 vaccinations administered per 100 million population for select countries and regions.

References

    1. Doorstop interview on 31 January 2021 Australian Government Department of Health. Published online January 2021. https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/doorstop-....
    1. Australia’s COVID-19 vaccine national roll-out strategy. Published online December 2020. https://www.health.gov.au/sites/default/files/documents/2021/01/australi....
    1. Schultz N.H., Sørvoll I.H., Michelsen A.E., et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021 doi: 10.1056/NEJMoa2104882. - DOI - PMC - PubMed
    1. Greinacher A., Thiele T., Warkentin T.E., Weisser K., Kyrle P.A., Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021 doi: 10.1056/NEJMoa2104840. - DOI - PMC - PubMed
    1. Australian Government Department of Health. ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns. Published online 8 April 2021. https://www.health.gov.au/news/atagi-statement-on-astrazeneca-vaccine-in....

Publication types

Substances